Page last updated: 2024-09-03

3-n-methylspiperone and mesulergine

3-n-methylspiperone has been researched along with mesulergine in 1 studies

Compound Research Comparison

Studies
(3-n-methylspiperone)
Trials
(3-n-methylspiperone)
Recent Studies (post-2010)
(3-n-methylspiperone)
Studies
(mesulergine)
Trials
(mesulergine)
Recent Studies (post-2010) (mesulergine)
155672651028

Protein Interaction Comparison

ProteinTaxonomy3-n-methylspiperone (IC50)mesulergine (IC50)
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.0019
5-hydroxytryptamine receptor 7Homo sapiens (human)0.205
5-hydroxytryptamine receptor 3ARattus norvegicus (Norway rat)0.0021
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.0052
5-hydroxytryptamine receptor 3BRattus norvegicus (Norway rat)0.0021

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Conklin, DS; Fitzgerald, LW; Hartig, PR; Iyer, G; Kostich, WA; Krause, CM; Largent, BL; Marshall, AP; Patterson, JP; Tran, DP1

Other Studies

1 other study(ies) available for 3-n-methylspiperone and mesulergine

ArticleYear
High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.
    Journal of neurochemistry, 1999, Volume: 72, Issue:5

    Topics: Amphetamines; Binding, Competitive; Cell Line; Ergolines; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hydrolysis; Isomerism; Ligands; Models, Biological; Phosphatidylinositols; Receptors, Serotonin; Recombinant Proteins; Serotonin Antagonists; Serotonin Receptor Agonists; Spiperone

1999